| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > PR > How Your Nonprofit Can Talk Back to the Media |
|
Advice You - How Your Nonprofit Can Talk Back to the Media
Tsk, tsk, tsk. That's the essence of Katherine Q. Seelye's recent New York Times' article on how use of websites and blogs enables news subjects to balance traditional journalism. Most of Seelye's article details compla According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ints about the way in which subjects of news articles and broadcasts are responding to media coverage of them. She writes that this practice "has led to a very uncivil discourse in which it seems to be O.K. to shout down ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in discredit, delegitimize and denigrate the people who are reporting stories and to pick at their methodology and ascribe motives to them that are often unfair." Hm. In the past errors or misrepresentation on the part of lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. traditional journalists have been all too easy to pass off. Subjects had no means other than Letters to the Editor to set the record straight. Sounds like Seelye forgets that all writers, editors and producers (includin here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe herself) have a slant which shapes every story they produce. After all, everybody has a perspective. That's what moves us up the food chain. And that slant or perspective, can, if let loose, evolve into incorrect, or un d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro air and biased reporting. News Subjects Fight Fire With Fire to Counter Inaccurate Coverage In the article, Seelye introduces the artillery of subjects who are talking back. Armed with audio tapes of i ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc terviews, email exchanges and notes on conversations, they publish these proofs on their websites and blogs, and do their best to make sure that content is picked up by Google and other search engines. This practice, cau easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ions Seelye, bears dangerous implications for the future of journalism. Example: Author Dave Eggers published a 10,000-word response (on his website) to what he considered to be the inappropriate tone nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically f an article on his memoir, A Heartbreaking Work of Staggering Genius. Eggers used his site to detail what was wrong with the article, backing up his response with email exchanges with article author David Kirkpatrick (w and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ o had requested that the emails remain private). Bloggers Pinpointed as Major Threat Despite the reach of website responses to media coverage, talking back via blogs has the potential for even greater ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi mpact. Seelye warns that the "power of blogs in exponential" as blog posts are available in perpetuity, at no cost, whereas newspaper articles are likely to be subsumed into pay-per-view article archives (like that of th ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a e Times). In addition, bloggers make it a practice to link to one another, further extending the reach of any post. She points to blogger and former CNN anchor Rebecca MacKinnon who asserts, "If you're one of a growing dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod umber of people with a blog, you now have a place where you can set the record straight." But MacKinnon moderates her words with the reminder that audiences don't have the time or desire to read source material on a reg cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin lar basis, and will continue to seek knowledgeable summaries of the news. As I see it, that's just where journalists come in. To distill the enormous amount of source material into cogent, accurate reporting with as litt tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen e slant as possible. And source content falls into place as useful backup when controversy arises, enabling audiences to shape their own perspectives on the issue at hand. Nonprofits, take heed and be prepared to add th t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel s strategy to your communications quiver. Audiences and Subjects Shifting Power Away From Old Line Media What's interesting here is that The Times acknowledges that these strategies "have forced journa ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ists to respond in a variety of ways, including becoming more open about their methods and techniques, and perhaps more conscious of how they filter information." In effect, having the opportunity to talk back shifts th y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products balance of power in message framing. And as it shifts the flow of information, it also shifts traditional definitions of audience and media. Goodbye to message control. Hello, 2006. You know that the way your nonprofit . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de is presented by the media is of vital importance to your success. I urge you to read Seelye's analysis of the fight against media message control carefully, and to arm yourself with some of the talk-back tactics detailed elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip above, if necessary. You'll find the article here: Take That Mr. Newsman: Answering Back to the News Media, Using the Internet tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How These Famous Entrepreneurs Can Teach and Inspire Us Finding Common Ground in Conversation-Debate-Negotiation and Uniting in a Common Cause
|